Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer was updated to display a newer site revision version (moving from v3.5.2 to v3.5.3). This represents a platform/release change and does not alter the study information presented.SummaryDifference0.1%

- Check14 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check71 days agoChange DetectedA new publication citation related to NODE-303 was added to the Publications section, describing a post hoc analysis of self-administered etripamil nasal spray in atrial fibrillation.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.2%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.